Q3 2021 patient services revenues of $316,329 represent a 235% increase over the previous quarter Field…
Category: Field Trip health
Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF)…
Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF)…
Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US
ATLANTA, Jan. 26, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field…
Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders
TORONTO, Jan. 07, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) (“Field…
Field Trip Health Ltd. Announces Closing of Bought Deal Financing
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (“Field Trip” or the “Company”) (CSE:…
Field Trip Health Ltd. Announces $15 Million Bought Deal Offering of Units
TORONTO, Dec. 9, 2020 /CNW/ – Field Trip Health Ltd. (“Field Trip” or the “Company“) (CSE: FTRP) (OTCBB: FTRPF),…
Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations
Pre-clinical studies demonstrate potential of FT-104, its novel psychedelic molecule, as preferable option for psychedelic therapies,…
Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field Trip”), a…
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program
AMSTERDAM, Nov. 17, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field…
Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP) (“Field Trip”), one…
Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development
Results confirm that Field Trip’s novel psychedelic molecule is similar in potency to psilocybin but with…